Concepedia

Hui-min Lei

HL

7

Publications

435

Citations

7

H-Index

2018

Active since

Affiliations

Shanghai Jiao Tong University(Current)

Shanghai Innovative Research Center of Traditional Chinese Medicine

State Key Laboratory of Oncogene and Related Genes

Renji Hospital

Fudan University

Hui-min Lei is an author at Shanghai Jiao Tong University specializing in lung cancer, medicine, and cell biology.

Top concepts

Publications per year

2018–2023

7

Publications

7

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase

Jiang-Kai Dong, Hui-min Lei, Qian Liang et al. · Theranostics · 2018 · 103 citations · Full text

NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells

Chunshuang Ma, Qian-Ming Lv, Keren Zhang et al. · Acta Pharmacologica Sinica · 2020 · 101 citations · Full text

, , +7

Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas

Hui-min Lei, Keren Zhang, Cong Hui Wang et al. · Theranostics · 2019 · 91 citations · Full text

A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer

Ke Huang, Qian Liang, Ye Zhou et al. · Cell Metabolism · 2019 · 85 citations · Full text

, , +12

A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma

Qian Liang, Miaomiao Gong, Jing-Hua Zou et al. · Drug Resistance Updates · 2023 · 26 citations · Full text

, , +16

Rows per page

1–5 of 7